Sommario

• • ·Editorial board

    Pagina :i

    

• Éditoriaux/ Editorials

  • ·Bismuth and pharmacovigilance

    Pagina :383-384

    Thierry Trenque

    Mappa Mappa
  • ·Adverse drug reaction monitoring: Doing it the French way – Act II

    Pagina :385-387

    Thomas Soeiro, Clémence Lacroix, Joëlle Micallef

    Mappa Mappa

• Droit médical/ Medical right

  • ·Le Comité de protection des personnes (CPP), carrefour des quiproquos

    The Committee for the Protection of Human Subjects in biomedical research, crossroads of misunderstandings

    Pagina :389-402

    Jean-Paul Demarez

    Riassunto Riassunto Mappa Mappa

• Pharmacologie clinique / Clinical pharmacology

  • ·Quality of evidence of the efficacy of therapeutic interventions on patient-important outcomes in Cochrane's systematic reviews’ abstracts: A survey

    Pagina :403-408

    Christine Maynié-François, Benoît Tudrej, Elodie Tawil, Florian Naudet, Caroline Huas, Denis Pouchain, Hélène Vaillant-Roussel, Nemat Jaafari, Rémy Boussageon

    Riassunto Riassunto Mappa Mappa  

• Pharmacocinétique /Pharmacokinetics

  • ·Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study

    Pagina :409-414

    Silvia Corcione, Amedeo De Nicolò, Tommaso Lupia, Francesco Vladimiro Segala, Anna Pensa, Riccardo Corgiat Loia, Maria Rosa Romeo, Giovanni Di Perri, Maurizio Stella, Antonio D’Avolio, Francesco Giuseppe De Rosa

    Riassunto Riassunto Mappa Mappa
  • ·Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment

    Pagina :415-424

    Frédéric J. Baud, Pascal Houzé, Pierre Carli, Lionel Lamhaut

    Riassunto Riassunto Mappa Mappa  

• Pharmacoépidemiologie/ Pharmacoepidemiology

  • ·Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study

    Pagina :425-433

    Canelle Mazaud, Laurence Fardet

    Riassunto Riassunto Mappa Mappa
  • ·Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database

    Pagina :435-440

    Patrick Blin, Magali Rouyer, Estelle Guiard, Frank Zerbib, Bertrand Diquet, Francis Mégraud, François Tison, Abdelilah Abouelfath, Régis Lassalle, Cécile Droz-Perroteau, Nicholas Moore

    Riassunto Riassunto Mappa Mappa   

• Pharmacovigilance/ Pharmacovigilance

  • ·The French pharmacovigilance surveys: A French distinctiveness, a real input

    Pagina :441-447

    Malak Abou Taam, Baptiste Jacquot, Claire Ferard, Anne-Charlotte Thery, Céline Mounier, Aurélie Grandvuillemin, Annie-Pierre Jonville-Béra, Marie-Christine Perault-Pochat, Réseau français des centres régionaux de pharmacovigilance

    Riassunto Riassunto Mappa Mappa  
  • ·TNF-? inhibitors and psychiatric adverse drug reactions in the spectrum of bipolar (manic) or psychotic disorders: Analysis from the French pharmacovigilance database

    Pagina :449-454

    Cécile Marie Yelnik, Louise Gaboriau, Nadine Petitpain, Hélène Théophile, Emmanuel Delaporte, Louise Carton, Sophie Gautier, Marc Lambert

    Riassunto Riassunto Mappa Mappa  
  • ·Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance

    Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis

    Pagina :455-465

    Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, Fabien Despas, Marion Sassier, Louise Triquet, Sylvie Picard, Emmanuel Oger, Elisabeth Polard, et le réseau français des Centres régionaux de pharmacovigilance

    Riassunto Riassunto Mappa Mappa   

• Thérapeutique/ Therapeutics

  • ·Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases

    Pagina :467-474

    Alia Fazaa, Yasmine Makhlouf, Amad Ben Ouhiba, Saoussen Miladi, Mariem Sellami, Kmar Ouenniche, Leila Souabni, Salma Kassab, Selma Chekili, Leith Zakraoui, Kawther Ben Abdelghani, Ahmed Laatar

    Riassunto Riassunto Mappa Mappa

• Lettres à la rédaction/ Letters to the editor

  • ·Drug-drug interactions between two beta-lactam antibiotics and valproic acid in the same patient

    Pagina :475-477

    Emna Gaies, Ikram Fazaa, Mouna Ben Sassi, Rim Charfi, Nadia Jebabli, Hanene El Jebari, Riadh Daghfous, Sameh Trabelsi

    Mappa Mappa  
  • ·Use of triptans during pregnancy? With caution!

    Pagina :477-478

    Isabelle Lacroix, Caroline Hurault-Delarue, Delphine Viard, Bruno Revol, Lemya Chaalel, Christine Damase-Michel

    Riassunto Riassunto Mappa Mappa
  • ·Warning on increased serious health complications related to non-medical use of nitrous oxide

    Pagina :478-479

    French Association of Addictovigilance Centres, Joelle Micallef, Michel Mallaret, Maryse Lapeyre-Mestre, Amélie Daveluy, Caroline Victorri-Vigneau, Hélène Peyrière, Danièle Debruyne, Sylvie Deheul, Régis Bordet, Cécile Chevallier, Marie-Christine Perault-Pochat, Reynald Le Boisselier, Frédéric Libert, Leila Chaouachi, Pierre Gillet

    Mappa Mappa
  • ·Cinderella side effect: Intravenous corticosteroid-induced bradycardia

    Pagina :480-481

    Matteo Coen, Peter Jandus, Victoria Rollason, Jörg Seebach, Jacques Serratrice

    Mappa Mappa  
  • ·Amlodipine and perindopril-induced hypertrichosis in a six-year-old girl: A case report

    Pagina :481-483

    Camille Azam, Geneviève Durrieu, Emilie Deuilhe, Margaux Lafaurie

    Mappa Mappa  
  • ·À propos d’un cas d’exacerbation sévère d’acouphènes lors d’un syndrome d’arrêt à la venlafaxine

    Tinnitus and venlafaxine discontinuation syndrome

    Pagina :483-486

    Guillaume Meyer, Alexis Erb, Bruno Michel, Coraline Hingray, Fabrice Duval, Hervé Javelot

    Mappa Mappa
  • ·Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma

    Pagina :486-488

    Ferdaous Yangui, Ahmed Zaiem, Saoussen Antit, Syrine Bellakhal, Lilia Zakhama, Mohamed Ridha Charfi

    Mappa Mappa  
  • ·Réaction lors de la perfusion de dalbavancine : à propos d’un cas

    Reaction during dalbavancin infusion: About one case

    Pagina :488-490

    Benjamin Valentin, Julien Dartus, Teddy Trouillez, Louise Gaboriau, Caroline Loiez, Hervé Dezèque, Pascal Odou, Bertrand Décaudin, Henri Migaud, Stéphanie Genay, Eric Senneville

    Mappa Mappa
  • ·Effets indésirables de l’antimoniate de méglumine dans la leishmaniose cutanée chez le sujet âgé

    Adverse drug reactions of meglumine antimoniate in elderly patients with cutaneous leishmaniasis

    Pagina :490-494

    Fatma Hammami, Emna Bahloul, Rym Sahnoun, Khadija Sellami, Abderrahmen Masmoudi, Sonia Boudaya, Madiha Mseddi, Meriem Amouri, Kamilia Ksouda, Khaled Zghal, Hamida Turki

    Mappa Mappa
  • ·Patient's therapeutic education on renin-angiotensin system inhibitors could limit iatrogenic acute kidney injuries. The RASIzen study

    Pagina :494-497

    Charles Verney, Blueberry Pierrel, Arnaud Le Flécher, Juliette Oliary, Anthony Vanjak, Jacques Blacher, Gaël Ensergueix, Célia Lloret-Linares

    Mappa Mappa  
  • ·Severe polyuria secondary to acyclovir induced-proximal tubulopathy

    Pagina :498-499

    Elise Yvin, François Beloncle, Sylvain Thépot, Laurence Lagarce, Jean-François Augusto, Anne-Sophie Garnier

    Mappa Mappa
  • ·Possible apixaban-induced agranulocytosis: A life-threatening adverse drug reaction causing by a widely prescribed drug

    Pagina :499-500

    Patrick Chen, Michèle Zamy, Roya Nili-Asgari, Florence Cymbalista, Robin Dhôte, Sébastien Abad

    Mappa Mappa
  • ·From domperidone to metopimazine: Anticipating the media impact of pharmacovigilance announcements

    Pagina :500-501

    Michaël Rochoy, Camille Potey, Sophie Gautier, Johana Béné

    Mappa Mappa
  • ·Bismuth encephalopathy and mineral waters: a new hypothesis on bismuth absorption

    Pagina :502-504

    Hubert Déchy

    Mappa Mappa  
  • ·Vitiligo and anti-tumor necrosis factors: Cases report

    Pagina :504-507

    Nada Jaouad, Kawther Ben Abdelghani, Meriem Sellami, Fadoua Khadiri, Bouchra Amine, Imane Elbinoune, Alia Fazaa, Ahmed Laatar, Rachid Bahiri

    Mappa Mappa  
  • ·Training in medical hypnosis and prolonged use of benzodiazepines: The French national health insurance data

    Pagina :507-510

    Léa Légereau, Marion Bonnard, Johann Tétart, Adriaan Barbaroux

    Mappa Mappa  
  • ·A flare-up of rheumatoid arthritis followed by adrenocorticotropic insufficiency induced by pembrolizumab: A case-report

    Pagina :510-512

    Julie Garon-Czmil, Diane Abs, Florence Granel-Brocard, Pierre Gillet, Mélissa Yelehe-Okouma

    Mappa Mappa
  • ·Is caspofungin efficient to treat invasive candidiasis requiring continuous veno-venous hemofiltration? A case report

    Pagina :512-515

    Jean-Herlé Raphalen, Ambroise Marçais, Perrine Parize, Benoit Pilmis, Agnès Lillo-Lelouet, Lionel Lamhaut, Frédéric J. Baud

    Mappa Mappa

• Analyse d'ouvrage/ Book review

  • ·Bégaud B. La France malade du médicament : 110 milliards d’euros plus tard. Ed. de l’ObservatoireParis (2020). [192 pp. ISBN 979-10-329-0949-2]

    Pagina :516

    Jean-Louis Montastruc